Marc-Steffen Raab

59PUBLICATIONS

345CO-AUTHORS

Gene and molecular therapyHaematologyGene expression (incl. microarray and other genome-wide approaches)Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (59)

Sort by Publication Date:

|Jul 06, 2026

Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

|Jul 01, 2026

Clinical decision support in hematological malignancies using a case-grounded AI agent.

|Jun 25, 2026

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

|Jun 12, 2026

Genomic features do not account for differences in multiple myeloma risk by ancestry.

|May 21, 2026

Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

|May 13, 2026

Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma.

Pageof 10

Frequent Collaborators

21 joint publications

Hartmut Goldschmidt

21 joint publications

Elias Mai

18 joint publications

Carsten Müller-Tidow

18 joint publications

Niels Weinhold

14 joint publications

Katja Weisel

Hans Salwender

Hermann Einsele

Martin Kortüm

Leo Rasche

Jesús San-Miguel Izquierdo

Frequent Collaborators

21 joint publications

Hartmut Goldschmidt

21 joint publications

Elias Mai

18 joint publications

Carsten Müller-Tidow

18 joint publications

Niels Weinhold